More locations: Remote in Spain
Remote within the assigned geography, with travel to customer sites; travel is required 75% of the time.
Agilent Technologies provides eProcurement services that help businesses buy supplies more efficiently. It offers a suite of electronic procurement tools that let clients load their pricing into existing purchasing platforms, access a hosted catalog, and complete transactions digitally without paper. The service connects pricing data to clients’ procurement systems, delivers an online catalog, and supports automated, paperless purchasing workflows. This makes purchasing faster and reduces manual steps. Compared with competitors, Agilent emphasizes automation, quick connectivity between pricing, catalogs, and purchasing platforms, and a reliable, scalable experience backed by its broad product range. The company aims to improve client productivity and lower procurement costs, helping customers buy what they need more easily while keeping prices clear and consistent.
Company Size
10,001+
Company Stage
IPO
Headquarters
Santa Clara, California
Founded
1999
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Remote Work Options
Performance Bonus
Stock Options
Agilent Technologies launched the S540MD slide scanner in the United States on 4 September. The FDA-cleared device can hold up to 540 glass slides at once and targets pathology labs managing high sample volumes and preparing for AI-assisted workflows. The scanner automates routine tasks and integrates with existing laboratory setups. It reached select European markets in January and is now available in Germany, the UK, France, and other European countries alongside the US. Agilent reported revenue of $1.88 billion for the quarter ended 31 July, up 8.1% year-on-year. Non-GAAP earnings per share rose 18%. Management raised full-year non-GAAP earnings guidance to $6.18 to $6.21 per share. The S540MD is a rebadged Hamamatsu NanoZoomer S540MD. Agilent has not disclosed pricing or revenue targets for the product.
Agilent Technologies announced that Koh Boon Hwee retired from its board of directors on 4 September 2026, after more than 20 years of service. Koh joined the board in 2003 and served as independent chair from 2017 until his retirement. Dow R. Wilson, a board member since 2018, was elected as the new chair. Wilson currently chairs the Audit and Finance Committee. The company also appointed Glenn Boehnlein to its board, effective 4 September 2026. Boehnlein spent 22 years at Stryker Corporation, serving as vice president and chief financial officer from 2016 until his retirement in 2025. He currently serves on the boards of Inogen and Sutter Health.
Agilent Technologies has launched the Cary 635 FTIR spectrometer, described as the smallest Fourier transform infrared analyser in its class. The compact instrument combines high-performance analysis with user-friendly operation, requiring minimal technical training. The spectrometer features solid ZnSe optical components for enhanced moisture resistance and improved sensitivity for analysing lower-concentration samples. Its modular architecture supports analysis of solids, liquids, powders, and gases, whilst permanently aligned optics enable rapid interchange of sampling modules. The device includes MicroLab software with step-by-step workflows and colour-coded results, allowing novice users to be trained quickly. Agilent generated $6.95 billion in revenue during fiscal year 2025 and employs approximately 18,000 people worldwide.
Agilent Technologies reported fiscal third-quarter revenue of $1.88 billion, up 8.1% year-over-year. Core revenue, excluding currency movements and M&A activity, grew 7.3%. The company's non-GAAP operating margin reached 28.3%, expanding 320 basis points. However, roughly 110 basis points of that improvement stemmed from tariff refunds, which also added $17 million to non-GAAP net income and approximately $0.06 to earnings per share. Excluding the refunds, operating margin expansion was approximately 210 basis points, supported by higher revenue and operational efficiencies. All three business segments reported revenue growth, with Life Sciences and Diagnostics Markets Group up 11%, CrossLab up 6%, and Applied Markets up 7%. For the full year, Agilent expects non-GAAP operating margin expansion of more than 130 basis points, including roughly 30 basis points from the tariff refunds.
Agilent Technologies reported 7.3% revenue growth in Q3 2026, driven by strong commercial execution and its Ignite Operating System. The company's pharma performance grew 12%, significantly outpacing peers due to robust demand in advanced therapeutics. China market showed notable improvement with 9% growth, exceeding flat expectations through competitive wins in pharma and food safety. Operating margin expanded 210 basis points, excluding tariff refunds, reflecting structural manufacturing improvements. The company raised its full-year core growth guidance to 5.8%-6.0%, citing sustained momentum in China and improving conditions across key markets. The Biocare acquisition, closed in late June, contributed $10 million in Q3 revenue. Agilent received an MSCI ESG upgrade to AAA, recognising its sustainability leadership and integration of green initiatives into product design.